Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Background. In 1999, meningococcal serogroup C conjugate (MCC) vaccines were introduced in the United Kingdom for those under 19 years of age. The impact of this intervention on asymptomatic carriage of meningococci was investigated to establish whether serogroup replacement or protection by herd immunity occurred. Methods. Multicenter surveys of carriage were conducted during vaccine introduction and on 2 successive years, resulting in a total of 48,309 samples, from which 8599 meningococci were isolated and characterized by genotyping and phenotyping. Results. A reduction in serogroup C carriage (rate ratio, 0.19) was observed that lasted at least 2 years with no evidence of serogroup replacement. Vaccine efficacy against carriage was 75%, and vaccination had a disproportionate impact on the carriage of sequence type (ST)-11 complex serogroup C meningococci that (rate ratio, 0.06); these meningococci also exhibited high rates of capsule expression. Conclusions. The impact of vaccination with MCC vaccine on the prevalence of carriage of group C meningococci was consistent with herd immunity. The high impact on the carriage of ST-11 complex serogroup C could be attributed to high levels of capsule expression. High vaccine efficacy against disease in young children, who were not protected long-term by the schedule initially used, is attributed to the high vaccine efficacy against carriage in older age groups.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The reduction in carriage lasted for at least 2 years after vaccine introduction, with no evidence of serogroup replacement (199).”
From Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis (2010) · cites this paper as [199]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The staden sequence analysis package
Staden, R. (1996) · Molecular Biotechnology · doi:10.1007/bf02900361 · Cited by 1,263
Multilocus Sequence Typing of Bacteria
Maiden, M. C. J. (2006) · Annual Review of Microbiology · doi:10.1146/annurev.micro.59.030804.121325 · Cited by 915
Self-citationEffectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction
Trotter, C. L., Andrews, N. J., Kaczmarski, E. B., Miller, E., & Ramsay, M. E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16725-1 · Cited by 571 · cited 1×
“This was fortuitous given that the infant schedule used for MCC vaccines in the United Kingdom at the time of vaccine introduction did not confer long term protection [27].”
BackgroundSelf-citationSequence type analysis and recombinational tests (START)
Jolley, K. A., Feil, E. J., Chan, M.-S., & Maiden, M. C. J. (2001) · Bioinformatics · doi:10.1093/bioinformatics/17.12.1230 · Cited by 512
Self-citationmlstdbNet – distributed multi-locus sequence typing (MLST) databases
Jolley, K. A., Chan, M.-S., & Maiden, M. C. (2004) · BMC Bioinformatics · doi:10.1186/1471-2105-5-86 · Cited by 501
Self-citationMiller, E., Salisbury, D., & Ramsay, M. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00299-7 · Cited by 482
Dagan, R., Melamed, R., Muallem, M., Piglansky, L., Greenberg, D., Abramson, O., Mendelman, P. M., Bohidar, N., & Yagupsky, P. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.6.1271 · Cited by 477
Immunologic Response of Man to Group B Meningococcal Polysaccharide Vaccines
Wyle, F. A., Artenstein, M. S., Brandt, B. L., Tramont, E. C., Kasper, D. L., Altieri, P. L., Berman, S. L., & Lowenthal, J. P. (1972) · Journal of Infectious Diseases · doi:10.1093/infdis/126.5.514 · Cited by 446
The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica
Cartwright, K. A. V., Stuart, J. M., Jones, D. M., & Noah, N. D. (1987) · Epidemiology and Infection · doi:10.1017/s0950268800066449 · Cited by 421
Self-citationMaiden, M. C., & Stuart, J. M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08679-8 · Cited by 418 · cited 4×
“bacteria [13], which, although rarely isolated from carriers, are”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 1
- 12. Jelfs J, Munro R, Ashton F, Rawlinson W, Caugant DA. Global study of variation in a new variant of the ET-37 complex of Neisseria meningitidis. In: Program and abstracts of the 11th International Pathogenic Neisseria Conference. Nice, France: Editions E.D.K., 1998 :5.
Cited by
Items 201–300 of 488
Trotter, C. L., Findlow, H., & Borrow, R. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05515-11 · Cited by 24
Perrett, K. P., Jin, C., Clutterbuck, E., John, T. M., Winter, A. P., Kibwana, E., Yu, L., Curtis, N. C., & Pollard, A. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200451 · Cited by 23
van Ravenhorst, M. B., den Hartog, G., van der Klis, F. R. M., van Rooijen, D. M., Sanders, E. A. M., & Berbers, G. A. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191261 · Cited by 23
Serra, L., Presa, J. V., Christensen, H., & Trotter, C. L. (2020) · Infectious Diseases and Therapy · doi:10.1007/s40121-020-00291-9 · Cited by 23
Stephens, D. S., & Apicella, M. A. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00213-7 · Cited by 23
Lemée, L., Hong, E., Etienne, M., Deghmane, A., Delbos, V., Terrade, A., Berthelot, G., Caron, F., & Taha, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107240 · Cited by 23
Real-world impact and effectiveness of MenACWY-TT
Villena, R., Kriz, P., Htar, M. T. T., Burman, C., Findlow, J., Balmer, P., & Jódar, L. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2251825 · Cited by 22
Meningococcal conjugate vaccines: optimizing global impact
Terranella, A., Cohn, A. C., & Clark (2011) · Infection and Drug Resistance · doi:10.2147/idr.s21545 · Cited by 22
Frandoloso, R., Chaudhuri, S., Frandoloso, G. C. P., Yu, R., & Schryvers, A. B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.595320 · Cited by 22
García, Y. R., Abitbol, V., Pellegrini, M., Bekkat-Berkani, R., & Soumahoro, L. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00519-2 · Cited by 22
Stoof, S. P., van der Klis, F. R. M., van Rooijen, D. M., Bogaert, D., Trzciński, K., Sanders, E. A. M., & Berbers, G. A. M. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.06.055 · Cited by 22
Opa Protein Repertoires of Disease-Causing and Carried Meningococci
Callaghan, M. J., Buckee, C. O., McCarthy, N. D., Pavón, A. B. I., Jolley, K. A., Faust, S. N., Gray, S. J., Kaczmarski, E. B., Levin, M., Kroll, J. S., et al. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00005-08 · Cited by 22
Self-citationUnlocking pathogen genotyping information for public health by mathematical modeling
Kretzschmar, M., Gomes, M. G. M., Coutinho, R. A., & Koopman, J. S. (2010) · Trends in Microbiology · doi:10.1016/j.tim.2010.06.008 · Cited by 21
ASSESSMENT OF VACCINATION PROGRAM EFFECTIVENESS: BASIC APPROACHES AND ISSUES
Briko, N. I., Lobzin, Y. V., Aa, B., Namazova-Baranova, L. S., Il'ina, S. V., Королева, И. С., Михайловна, Х. С., Sv, S., Tatochenko, V. K., Mayanskiy, N. A., et al. (2014) · Педиатрическая фармакология · doi:10.15690/pf.v11i4.1057 · Cited by 21
Tryfinopoulou, K., Κεσανόπουλος, Κ., Xirogianni, A., Μαρμαράς, Ν., Papandreou, A., Papaevangelou, V., Tsolia, M. N., Jasir, A., & Tzanakaki, G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167404 · Cited by 21
MenACWY vaccination campaign for adolescents in the Netherlands: Uptake and its determinants
Lima, P. D. O. B., van Lier, A., de Melker, H. E., Ferreira, J. A., van der Vliet, H. J., & Knol, M. J. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.05.087 · Cited by 21
Broad vaccine protection against Neisseria meningitidis using factor H binding protein
Findlow, J., Bayliss, C. D., Beernink, P. T., Borrow, R., Liberator, P., & Balmer, P. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.08.031 · Cited by 21
Clinical and Laboratory Evidence for Neisseria Meningitidis Biofilms
Neil, R. B., & Apicella, M. A. (2009) · Future Microbiology · doi:10.2217/fmb.09.27 · Cited by 21
The 2011 Garrod Lecture: From penicillin-binding proteins to molecular epidemiology
Spratt, B. G. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks109 · Cited by 21
Neisseria lactamica Controlled Human Infection Model
Dale, A. P., Gbesemete, D. F., Read, R. C., & Laver, J. R. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1900-1_21 · Cited by 20
Australian Meningococcal Surveillance Programme annual report, 2014
Lahra, M. M., & Enriquez, R. P. (2016) · Communicable Diseases Intelligence · doi:10.33321/cdi.2016.40.17 · Cited by 20
Pajón, R., Buckwalter, C. M., Johswich, K. O., Gray‐Owen, S. D., & Granoff, D. M. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.01.057 · Cited by 20
Lalwani, S. K., Agarkhedkar, S., Gogtay, N., Palkar, S. H., Agarkhedkar, S., Thatte, U. M., Vakil, H. B., Jonnalagedda, R., Pedotti, P., Hoyle, M., et al. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2015.07.003 · Cited by 20
Lupisan, S., Limkittikul, K., Sosa, N., Chanthavanich, P., Bianco, V., Baine, Y., der Wielen, M. V., & Miller, J. M. (2013) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00162-13 · Cited by 20
de Moraes, C., de Moraes, J. C., da Silva, G. D. M., & Duarte, E. C. (2017) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760160173 · Cited by 20
Clarke, E. T., Williams, N., Dull, P. M., Findlow, J., Borrow, R., Finn, A. H. R., & Heyderman, R. S. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.70 · Cited by 19
Zuckerman, J. N., Bröker, M., & Worth, C. (2010) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2010.04.004 · Cited by 19
The Long Road to an Effective Vaccine for Meningococcus Group B (MenB)
Shea, M. W. (2013) · Annals of Medicine and Surgery · doi:10.1016/s2049-0801(13)70037-2 · Cited by 19
FightingNeisseria meningitidis: past and current vaccination strategies
Piccini, G., Torelli, A., Gianchecchi, E., Piccirella, S., & Montomoli, E. (2016) · Expert Review of Vaccines · doi:10.1080/14760584.2016.1187068 · Cited by 19
Gianchecchi, E., Piccini, G., Torelli, A., Rappuoli, R., & Montomoli, E. (2017) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1333422 · Cited by 19
Australian Meningococcal Surveillance Programme Annual Report, 2022
Lahra, M. M., George, C. R. R., van Hal, S. J., & Hogan, T. R. (2023) · Communicable Diseases Intelligence · doi:10.33321/cdi.2023.47.44 · Cited by 19
Epidemiology and economic burden of meningococcal disease in Germany: A systematic review
Gruhn, S., Witte, J., Greiner, W., Damm, O., Dietzsch, M., Kramer, R., & Knuf, M. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.02.043 · Cited by 19
Yamoah, P., Mensah, K. B., Attakorah, J., Padayachee, N., Oosthuizen, F., & Bangalee, V. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2109365 · Cited by 19
Porteous, G. H., Hanson, N. A., Sueda, L. A., Hoaglan, C. D., Dahl, A. B., Ohlson, B. B., Schmidt, B. E., Wang, C. C., & Fagley, R. E. (2016) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000001196 · Cited by 19
Santos-Neto, J. F., Ferreira, V. M., Feitosa, C. A., Martinez-Silveira, M. S., & Campos, L. C. (2019) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2019.06.006 · Cited by 19
Carr, J., Plested, E. L., Aley, P. K., Camara, S., Davis, K., MacLennan, J. M., Gray, S. J., Faust, S. N., Borrow, R., Christensen, H., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-037358 · Cited by 19
Self-citationRüttimann, R. W., de Gentile, A. S., Parra, M. M., Sáez‐Llorens, X., Sáfadi, M. A. P., & Santolaya, M. E. (2014) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000228 · Cited by 19
Villena, R., Sáfadi, M. A. P., de Gentile, A. S., Pujadas, M., de la Maza, V., George, S., & Torres, J. P. (2023) · Vaccines · doi:10.3390/vaccines11121841 · Cited by 18
What is the best way to use conjugate vaccines?
Seale, A. C., & Finn, A. H. R. (2011) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283468996 · Cited by 18
Finn, A. H. R., Morales‐Aza, B. M., Sikora, P., Giles, J., Lethem, R., Marlais, M., Thors, V. S., Pollard, A. J., Faust, S. N., Heath, P. T., et al. (2016) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001237 · Cited by 18
Can we, should we, eradicate the meningococcus?
Maiden, M. C. J., & Frosch, M. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.12.068 · Cited by 18
Self-citationRodrigues, F. M. P., Morales‐Aza, B. M., Christensen, H., Giles, J., Ferreira, M., Sikora, P., Madanelo, I., Lucidarme, J., Januário, L., & Finn, A. H. R. (2015) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000860 · Cited by 18
Effect of Increased CRM197Carrier Protein Dose on Meningococcal C Bactericidal Antibody Response
Lee, L. H., & Blake, M. S. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05438-11 · Cited by 18
O’Connor, D., Clutterbuck, E., Thompson, A., Snape, M. D., Ramasamy, M., Kelly, D. F., & Pollard, A. J. (2017) · Genome Medicine · doi:10.1186/s13073-017-0400-x · Cited by 18
Controlling serogroup B invasive meningococcal disease: the Canadian perspective
Bettinger, J. A., Deeks, S. L., Halperin, S. A., Tsang, R. S. W., & Scheifele, D. W. (2013) · Expert Review of Vaccines · doi:10.1586/erv.13.30 · Cited by 17
Trayner, K. M. A., Anderson, N., & Cameron, J. C. (2018) · Health Education Journal · doi:10.1177/0017896918796049 · Cited by 17
Self-citationPreventing invasive meningococcal disease in early infancy
Presa, J. V., Serra, L., Weil-Olivier, C., & York, L. J. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1979846 · Cited by 17
Harder, T., Koch, J., Wichmann, O., & Hellenbrand, W. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.05.001 · Cited by 17
Glycoconjugate Vaccines: The Regulatory Framework
Jones, C. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2874-3_14 · Cited by 17
A world without bacterial meningitis: how genomic epidemiology can inform vaccination strategy
Rodrigues, C. M. C., & Maiden, M. C. J. (2018) · F1000Research · doi:10.12688/f1000research.13793.1 · Cited by 17
Self-citationLinares-Pérez, N., Toledo-Romaní, M. E., Santana-Mederos, D., García-Fariñas, A., García-Rivera, D., Valdés-Balbín, Y., & Vérez-Bencomo, V. G. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.03.011 · Cited by 16
Meningococcal Disease in Pediatric Age: A Focus on Epidemiology and Prevention
Pietro, G. M. D., Biffi, G., Castellazzi, M. L., Tagliabue, C., Pinzani, R., Bosis, S., & Marchisio, P. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19074035 · Cited by 16
Yezli, S., Yassin, Y. M., Mushi, A., Alabdullatif, L., Alburayh, M., Alotaibi, B. M., Khan, A. A., Walsh, L., Lekshmi, A., Walker, A., et al. (2023) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2023.102581 · Cited by 16
Self-citationVogel, U. F., Stefanelli, P., Vázquez, J. A., Taha, M., Claus, H., & Donnelly, J. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.12.061 · Cited by 16
Meningococcal vaccines: a neglected topic in travel medicine?
Wilder‐Smith, A. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.102 · Cited by 16
A Longitudinal Epidemiology Study of Meningococcal Carriage in Students 13 to 25 Years Old in Quebec
Gilca, R., Wals, P. D., Nolan, S. M., Kitchin, N. R. E., Eiden, J., Jiang, Q. L., Jones, C. H., Jansen, K. U., Anderson, A. S., & Pedneault, L. (2018) · mSphere · doi:10.1128/msphere.00427-18 · Cited by 16
Introduction of a second MenB vaccine into Europe – needs and opportunities for public health
Findlow, J., Nuttens, C., & Kriz, P. (2019) · Expert Review of Vaccines · doi:10.1080/14760584.2019.1578217 · Cited by 16
Stawasz, A., Huang, L., Kirby, P., & Bloom, D. E. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00261 · Cited by 16
Stefanelli, P., Fazio, C., Neri, A., Boros, S., Renna, G., & Pompa, M. G. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.06.032 · Cited by 16
Giannina Izquierdo, C., Torres, J. P., Santolaya, M. E., Valenzuela, M. T., Vega, J., & Chomalí, M. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1010885 · Cited by 16
de Waure, C., Miglietta, A., Nedovic, D., Mereu, G., & Ricciardi, W. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1078951 · Cited by 16
Serogroup A meningococcal conjugate vaccines in Africa
Kristiansen, P. A., Jørgensen, H. J., & Caugant, D. A. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.1084232 · Cited by 16
Hebert, C., Hall, C. M., & Odoms, L. N. J. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.19204 · Cited by 16
Molecular epidemiology of meningococci: Application of DNA sequence typing
Vogel, U. F. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.04.017 · Cited by 16
Germinario, C. A., Tafuri, S., Napoli, C., Montagna, M. T., Balducci, M. T., Fortunato, F., Martinelli, D., & Prato, R. (2010) · Human Vaccines · doi:10.4161/hv.6.12.13145 · Cited by 16
The Influence of IS1301 in the Capsule Biosynthesis Locus on Meningococcal Carriage and Disease
Kugelberg, E., Gollan, B., Farrance, C., Bratcher, H. B., Lucidarme, J., Ibarz-Pavón, A. B., Maiden, M. C. J., Borrow, R., & Tang, C. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009413 · Cited by 16
Self-citationFrom genes to vaccine: A breakthrough in the prevention of meningococcal group B disease
Major, M., Moss, S., & Gold, R. (2011) · Paediatrics & Child Health · doi:10.1093/pch/16.8.e61 · Cited by 15
Fast and accurate dynamic estimation of field effectiveness of meningococcal vaccines
Argante, L., Tizzoni, M., & Medini, D. (2016) · BMC Medicine · doi:10.1186/s12916-016-0642-2 · Cited by 15
Australian Meningococcal Surveillance Programme annual report, 2016
Lahra, M. M., Enriquez, R. P., & National Neisseria Network (2017) · Communicable Diseases Intelligence · doi:10.33321/cdi.2017.41.46 · Cited by 15
Antibody Persistence in Australian Adolescents Following Meningococcal C Conjugate Vaccination
Perrett, K. P., Richmond, P., Borrow, R., Nolan, T. M., & McVernon, J. (2015) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000541 · Cited by 15
Foster, R., Carlring, J., Lees, A., Borrow, R., Ramsay, M. E., Kacsmarski, E., Miller, E., McKendrick, M. W., Heath, A. W., & Read, R. C. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00481-09 · Cited by 15
Wing, J. B., Smart, L. E., Borrow, R., Findlow, J., Findlow, H., Heath, A. W., & Read, R. C. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir198 · Cited by 15
University vaccine campaign increases meningococcal ACWY vaccine coverage
Turner, D. P. J., Oldfield, N. J., & Bayliss, C. D. (2017) · Public Health · doi:10.1016/j.puhe.2016.12.010 · Cited by 15
Terranova, L., Principi, N., Bianchini, S., Pietro, G. M. D., Umbrello, G., Madini, B., & Esposito, S. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1450121 · Cited by 15
Detection of Neisseria meningitidis in saliva and oropharyngeal samples from college students
Miellet, W. R., Mariman, R., Pluister, G. N., de Jong, L. J., Grift, I., Wijkstra, S., van Logchem, E. M., van Veldhuizen, J., Immink, M.-M., Wijmenga‐Monsuur, A. J., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-02555-x · Cited by 15
Meningococcal tetravalent conjugate vaccine
Smith, M. J. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712590802538455 · Cited by 15
Variations inNeisseria meningitidiscarriage by socioeconomic status: a cross-sectional study
Cleary, P. R., Calvert, N., Gee, S., Graham, C., Gray, S. J., Kaczmarski, E. B., Morphet, J., Murphy, L., Verlander, N. Q., Wood, T., et al. (2015) · Journal of Public Health · doi:10.1093/pubmed/fdv015 · Cited by 15
Self-citationChiappini, E., Venturini, E., Bonsignori, F., Galli, L., & de Martino, M. (2010) · Acta Paediatrica · doi:10.1111/j.1651-2227.2010.01908.x · Cited by 14
Oldfield, N. J., Harrison, O. B., Bayliss, C. D., Maiden, M. C. J., Ala’Aldeen, D. A. A., & Turner, D. P. J. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw008 · Cited by 14
Self-citationMacêdo, L. E. N., Ferreira, V. M., Feitosa, C. A., Nunes, A. M. P. B., Campos, L. C., & Sáfadi, M. A. P. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1415682 · Cited by 14
4CMenB vaccine and its role in preventing transmission and inducing herd immunity
McMillan, M., Marshall, H. S., & Richmond, P. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2022.2003708 · Cited by 14
Findlow, J., Borrow, R., Stephens, D. S., Liberator, P., Anderson, A. S., Balmer, P., & Jódar, L. (2022) · Expert Review of Vaccines · doi:10.1080/14760584.2022.2064850 · Cited by 14
de Whalley, P., Snape, M. D., Kelly, D. F., Banner, C., Lewis, S., Diggle, L., John, T. M., Yu, L., Omar, O., Borkowski, A., et al. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318224fb14 · Cited by 14
Meningococcal Capsular Group A, C, W, and Y Conjugate Vaccines
Harrison, L. H., Granoff, D. M., & Pollard, A. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00038-9 · Cited by 14
Neri, A., Fazio, C., Ambrosio, L., Vacca, P., Barbui, A., Daprai, L., Vocale, C., Santino, I., Conte, M., Rossi, L., et al. (2019) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2019.03.004 · Cited by 14
Pandemic (H1N1) 2009 in Neonates, Japan
Takahashi, N., Kitajima, H., Kusuda, S., Morioka, I., & Itabashi, K. (2011) · Emerging infectious diseases · doi:10.3201/eid1709.101803 · Cited by 13
Khatami, A., Snape, M. D., Wysocki, J., John, T. M., Westcar, S., Mesaros, N. E., Peddiraju, K., Boutriau, D., Yu, L., & Pollard, A. J. (2012) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318262528c · Cited by 13
Challenges in immunisation against bacterial infection in children
Trück, J., & Pollard, A. J. (2010) · Early Human Development · doi:10.1016/j.earlhumdev.2010.08.010 · Cited by 13
Yadav, S., Manglani, M. V., Narayana, D. H. A., Sharma, S., Ravish, H. S., Arora, R. R., Castells, V. B., Arya, S., & Oster, P. (2014) · Indian Pediatrics · doi:10.1007/s13312-014-0435-7 · Cited by 13
Bettinger, J. A., Scheifele, D. W., Halperin, S. A., Kellner, J. D., Vanderkooi, O. G., Schryvers, A. B., Serres, G. D., & Alcantara, J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.034 · Cited by 13
Are lactoferrin receptors in Gram-negative bacteria viable vaccine targets?
Chan, C., Andisi, V. F., Ng, D., Ostan, N., Yunker, W. K., & Schryvers, A. B. (2018) · BioMetals · doi:10.1007/s10534-018-0105-7 · Cited by 13
Meningococcal B vaccination strategies and their practical application in Italy
Gasparini, R., Amicizia, D., Lai, P. L., & Panatto, D. (2015) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2015.56.3.508 · Cited by 12
Zografaki, I., Detsis, M., del Amo, M., Iantomasi, R., Maia, A., Montuori, E. A., & Méndez, C. (2023) · Expert Review of Vaccines · doi:10.1080/14760584.2023.2225596 · Cited by 12
de Voer, R. M., van der Klis, F. R. M., Schepp, R. M., Rijkers, G. T., Sanders, E. A. M., & Berbers, G. A. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023497 · Cited by 12
Meningococcal Capsular Group B Vaccines
Granoff, D. M., Pollard, A. J., & Harrison, L. H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00053-5 · Cited by 12
Bennett, D. E., O’Lorcain, P. P., Morgan, S., Cotter, S. M., Cafferkey, M., & Cunney, R. (2019) · Epidemiology and Infection · doi:10.1017/s0950268819000396 · Cited by 12
Maiden, M. C. J., & MacLennan, J. M. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu599 · Cited by 12
Self-citationMeningococcal vaccine evolution.
Bona, G., & Guidi, C. (2012) · Journal of preventive medicine and hygiene · Cited by 11
Population Genetics of Neisseria meningitidis
Vogel, U. F., Schoen, C. U., & Elias, J. (2010) · Wiley eBooks · doi:10.1002/9780470600122.ch13 · Cited by 12
Optimizing Protection Against Meningococcal Disease
Reisinger, K. S., BLACK, S. B., & Stoddard, J. J. (2010) · Clinical Pediatrics · doi:10.1177/0009922809354327 · Cited by 11
Metadata
- Authors
- Maiden, M. C. J., Ibarz-Pavón, A. B., Urwin, R., Gray, S. J., Andrews, N. J., Clarke, S. C., Walker, A. M., Evans, M. R., Kroll, J. S., Neal, K. R., Ala'Aldeen, D. A. A., Crook, D. W., Cann, K., Harrison, S., Cunningham, R., Baxter, D., Kaczmarski, E., MacLennan, J., Cameron, J. C., & Stuart, J. M.
- Affiliations
- John Radcliffe Hospital (GB)
- Health Protection Agency (GB)
- Health Protection Agency Centre for Infections, London
- University of Southampton (GB)
- Bangor University (GB)
- National Public Health Service for Wales, Unit 1, Parc Nantgarw, Cardiff
- Imperial College London (GB)
- University of Nottingham (GB)
- Division of Microbiology, School of Molecular Medical Sciences, Institute of Infection Immunity and Inflammation University of Nottingham
- South West Peninsula Health Protection Unit, Lescaze Offices, Dartington, Devon
- Derriford Hospital (GB)
- University of Manchester (GB)
- Manchester Royal Infirmary (GB)
- Health Protection Scotland (GB)
- Corresponding author
- Maiden, Martin C J
- ORCID
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-03-01
- Volume
- 197
- Issue
- 5
- Pages
- 737-743
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- PMC
- PMC6767871
- OpenAlex
- W2171028861
- Cited by
- 442
- References
- 41
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 9 · 2023: 16 · 2022: 10 · 2021: 21 · 2020: 18 · 2019: 21 · 2018: 29 · 2017: 32 · 2016: 24 · 2015: 40 · 2014: 22 · 2013: 28 · 2012: 45
- FWCI
- 35.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Funders
- Wellcome Trust
- Scottish Executive Health Department
- Meningitis Trust
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Keywords
- meningococcal serogroup C, conjugate vaccines, asymptomatic carriage, herd immunity, serogroup replacement, capsule expression, vaccine efficacy, young children, United Kingdom
- MeSH terms
- Adolescent, Adult, Carrier State, Cross-Sectional Studies, United Kingdom, Humans, Meningococcal Infections, Neisseria meningitidis, Serotyping, Meningococcal Vaccines, Immunity, Herd, Mass Vaccination, Neisseria meningitidis, Serogroup C
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.